I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The cost-effectiveness analysis of serplulimab versus regor..:
Ma, Yue
;
Zhou, Jiting
;
Ye, Yuxin
...
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1113346
RT Journal T1
The cost-effectiveness analysis of serplulimab versus regorafenib for treating previously treated unresectable or metastatic microsatellite instability-high or deficient mismatch repair colorectal cancer in China
UL https://suche.suub.uni-bremen.de/peid=cr-10.3389_fonc.2023.1113346&Exemplar=1&LAN=DE A1 Ma, Yue A1 Zhou, Jiting A1 Ye, Yuxin A1 Wang, Xintian A1 Ma, Aixia A1 Li, Hongchao PB Frontiers Media SA YR 2023 SN 2234-943X JF Frontiers in Oncology VO 13 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1113346 DO https://doi.org/10.3389/fonc.2023.1113346 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)